Nippon India Pharma Fund vs Mirae Asset Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8265 Cr | ₹2771 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹99 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 02 Jul 2018 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | BSE Healthcare |
| Turn Over | 21% | 15% |
| Expense Ratio | 1.82 | 1.92 |
| Manager | Sailesh Raj Bhan | Vrijesh Kasera |
| ISIN Code | INF204K01968 | INF769K01EA2 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Month | -3.48% | -3.94% |
| 6 Month | -9.21% | -9.19% |
| 1 Year | 1.71% | 0.37% |
| 3 Year | 20.8% | 20.23% |
| 5 Year | 14.86% | 15.2% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 6 Month | -0.33% | -0.75% |
| 1 Year | 3.37% | 4.1% |
| 3 Year | 13.78% | 14.75% |
| 5 Year | 15.1% | 15.02% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| 1 Year | 16.54% | 18.85% |
| 3 Year | 21% | 20.62% |
| 5 Year | 20.33% | 22.96% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Standard Deviation | 15.10% | 16.17% |
| Sharp | 0.96% | 0.90% |
| Beta | 0.91% | 0.99% |
| Alpha | -0.54% | -1.63% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Vrijesh Kasera |
| Total AUM | ₹96086 Cr | ₹12061 Cr |
| Funds Managed | 5 | 4 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 3.47 | 6.66 |
| Mid Cap | 34.55 | 36.33 |
| Small Cap | 29.97 | 23.1 |
| Large Cap | 32.01 | 33.91 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
|---|---|---|
| Others | 2.63 | 0.54 |
| Healthcare | 97.37 | 98.24 |
| Basic Materials | - | 1.22 |
Top Comparisons
ICICI Prudential Value Fund - Growth
3Y Returns20.59%
Canara Robeco Value Fund - Regular Plan - Growth Option
3Y Returns17.35%
SBI Equity Savings Fund - Regular Plan - Growth
3Y Returns11.6%
Baroda BNP Paribas Equity Savings Fund - Regular Plan - Growth
3Y Returns10.32%
ICICI Prudential Liquid Fund - Growth
3Y Returns6.91%
Sundaram Liquid Fund (G)
3Y Returns6.86%
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns18.26%
ADITYA BIRLA SUN LIFE US TREASURY 3-10 YEAR BOND ETFS PASSIVE FOF - REGULAR PLAN - GROWTH
3Y Returns0%